Press Releases Year All News202020192018201720162015 Forty Seven Inc. Receives $5 Million Grant from The California Institute for Regenerative Medicine (CIRM) to Support Ongoing Clinical Trial in Acute Myeloid Leukemia December 6, 2017 Forty Seven Inc. Completes $75 Million Series B Financing October 17, 2017 Forty Seven Inc. receives grants totaling $14.2 million from CIRM and LLS to support clinical trials of CD47-blocking antibody April 5, 2017 Forty Seven Inc. Announces Mark McCamish, M.D., Ph.D., to Join as CEO on May 1st March 20, 2017